APM
DCPH

Avidity Partners Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Avidity Partners Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,126,000
Closed -$18.5M – 101
2022
Q4 		$18.5M Sell
1,126,000
-65,800
-6% -$1.07M 0.43% 53
2022
Q3 		$22M Sell
1,191,800
-8,200
-0.7% -$129K 0.48% 50
2022
Q2 		$15.8M Buy
+1,200,000
New +$13.2M 0.36% 43
2020
Q3 		– Sell
-156,266
Closed -$9.33M – 90
2020
Q2 		$9.33M Buy
+156,266
New +$8.36M 0.6% 46

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return